AU2002224096A1 - Method of testing anticancer agent-sensitivity of tumor cells - Google Patents

Method of testing anticancer agent-sensitivity of tumor cells

Info

Publication number
AU2002224096A1
AU2002224096A1 AU2002224096A AU2002224096A AU2002224096A1 AU 2002224096 A1 AU2002224096 A1 AU 2002224096A1 AU 2002224096 A AU2002224096 A AU 2002224096A AU 2002224096 A AU2002224096 A AU 2002224096A AU 2002224096 A1 AU2002224096 A1 AU 2002224096A1
Authority
AU
Australia
Prior art keywords
sensitivity
tumor cells
anticancer agent
testing
testing anticancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002224096A
Other versions
AU2002224096B2 (en
Inventor
Hiroyuki Kato
Takatoshi Kawai
Junro Kuromitsu
Takeshi Nagasu
Takashi Owa
Akira Yokoi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Priority claimed from PCT/JP2001/010282 external-priority patent/WO2002042493A1/en
Publication of AU2002224096A1 publication Critical patent/AU2002224096A1/en
Application granted granted Critical
Publication of AU2002224096B2 publication Critical patent/AU2002224096B2/en
Assigned to EISAI R&D MANAGEMENT CO., LTD. reassignment EISAI R&D MANAGEMENT CO., LTD. Request for Assignment Assignors: EISAI CO., LTD.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002224096A 2000-11-24 2001-11-26 Method of testing anticancer agent-sensitivity of tumor cells Ceased AU2002224096B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-357398 2000-11-24
JP2000357398 2000-11-24
PCT/JP2001/010282 WO2002042493A1 (en) 2000-11-24 2001-11-26 Method of testing anticancer agent-sensitivity of tumor cells

Publications (2)

Publication Number Publication Date
AU2002224096A1 true AU2002224096A1 (en) 2002-08-08
AU2002224096B2 AU2002224096B2 (en) 2006-07-27

Family

ID=18829473

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2409602A Pending AU2409602A (en) 2000-11-24 2001-11-26 Method of testing anticancer agent-sensitivity of tumor cells
AU2002224096A Ceased AU2002224096B2 (en) 2000-11-24 2001-11-26 Method of testing anticancer agent-sensitivity of tumor cells

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2409602A Pending AU2409602A (en) 2000-11-24 2001-11-26 Method of testing anticancer agent-sensitivity of tumor cells

Country Status (7)

Country Link
US (1) US7445892B2 (en)
EP (1) EP1336660A4 (en)
KR (2) KR100858644B1 (en)
CN (3) CN1721554B (en)
AU (2) AU2409602A (en)
CA (1) CA2429688A1 (en)
WO (1) WO2002042493A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113549696A (en) * 2021-09-23 2021-10-26 广州医科大学附属肿瘤医院 Tumor marker SORCS2 and application thereof

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2343843T3 (en) * 2004-02-06 2010-08-11 EISAI R&D MANAGEMENT CO., LTD. PROCEDURE TO EXAMINE THE SENSITIVITY OF CANCER CELLS TO AN ANTI-TARGET AGENT.
WO2005085860A2 (en) * 2004-02-27 2005-09-15 Institut Curie New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
US20100093767A1 (en) * 2004-12-03 2010-04-15 Takeda San Diego, Inc. Mitotic Kinase Inhibitors
WO2007086605A1 (en) * 2006-01-27 2007-08-02 Eisai R & D Management Co., Ltd. Method for prediction of the effect of sulfonamide compound
US20100291592A1 (en) 2006-04-20 2010-11-18 Taro Semba Novel marker for sensitivity against sulfonamide compound
JP2012136435A (en) * 2009-03-30 2012-07-19 Eisai R & D Management Co Ltd Method for examining sensitivity of tumor tissue
CN103088102B (en) * 2013-01-09 2015-05-20 苏州麦克威尔生物医药科技有限公司 Sterile instant type medicine film and tumor drug sensitivity testing application thereof
CN109781985B (en) * 2019-02-27 2021-10-29 中山大学肿瘤防治中心 Kit for detecting cancer radiotherapy sensitivity and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683492B2 (en) * 1993-09-10 1997-11-13 Eisai R&D Management Co., Ltd. Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
WO2006036025A1 (en) 2004-09-30 2006-04-06 Eisai R & D Management Co., Ltd. Method of evaluating sensitivity of tumor cell to sulfonamide-containing compound

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113549696A (en) * 2021-09-23 2021-10-26 广州医科大学附属肿瘤医院 Tumor marker SORCS2 and application thereof

Similar Documents

Publication Publication Date Title
AU2002215345A1 (en) Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
AU3867400A (en) Methods of using bioelastomers
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2557500A (en) Methods of making compounds
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2001275007A1 (en) Methods of testing materials
AU2002224096A1 (en) Method of testing anticancer agent-sensitivity of tumor cells
AU2002307466A1 (en) Method for detecting breast cancer cells
AU2409602A (en) Method of testing anticancer agent-sensitivity of tumor cells
AU7817500A (en) Method of tumor imaging
AU7332800A (en) Card construction, methods of making and using
AU2002233981A1 (en) Method of testing adequacy of specimen cells
AU2881301A (en) Cancer cell implantation inhibitors
AU2001241779A1 (en) Method of treatment of prostate cancer
AU2728901A (en) Method of making hydrofluorocarbons
AUPQ015299A0 (en) Ph probe
AU2001258659A1 (en) Improved methods of transfection
AU7746900A (en) Method of preparing phosphorus
AU2000261768A1 (en) An improved process for the preparation of docetaxel
AU2001246862A1 (en) Method of detecting cancer
AU4056500A (en) Methods for detecting cancer cells
AU2002319080A1 (en) Method for the diagnosis and therapy of renal cell carcinoma
AU2001272558A1 (en) Method for identifying metastatic tumor cells
AU2001290241A1 (en) Tumor cell proliferation inhibitors
AU6389000A (en) Sonoporation of tumors